New combo therapy aims to outperform standard care for advanced liver cancer
Disease control
Recruiting now
This Phase 3 trial tests whether a chemotherapy infusion directly into the liver (HAIC) plus immunotherapy drugs works better than the standard chemo-embolization procedure (TACE) plus the same immunotherapy for people with intermediate-stage liver cancer that has spread extensiv…
Phase: PHASE3 • Sponsor: Binkui Li • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC